By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC.
I’m not a resolutions person but I’ve always loved the start of the year – there is something about turning the page on a new chapter that is refreshing. This year especially feels like a fresh start, after the weird year that was 2025. These past 12 months are probably best described as a constant sensation of vertigo… we thought biotech may benefit from a “pro-business” administration in January, then “Liberation Day” chaos ensued when it felt like the broader markets were headed for a recession, then from late summer to…